Genome Atlantic

Immunovaccine Technologies is a biotechnology company based in Halifax, NS, specializing in the development of innovative vaccine technologies. With a focus on advancing immunotherapies for infectious diseases and cancer, the company utilizes its platform to create novel vaccine candidates for various medical applications. Generated from their business information

Genome Atlantic, based in Halifax, NS, is a leading organization dedicated to harnessing genomic insights and innovations to address real-world challenges faced by industries and governments in Atlantic Canada. With a focus on sustainability and health outcomes, the organization collaborates with both private and public sector partners to drive advancements in agriculture, aquaculture, forestry, and clean technology. Since its inception, Genome Atlantic has generated over $150 million in applied research and development funding, emphasizing client-driven projects that tackle strategic opportunities. The organization is recognized for its impactful contributions, including initiatives in biodiversity monitoring, climate-resilient forestry, and health innovations, positioning it as a pivotal player in the region's genomic landscape. Generated from the website

Portland Physiotherapy Health & Wellness Centre offers programs and services that facilitate recovery and restore optimal quality of life and health.